Janus Henderson Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $157K | Hold |
91,341
| – | – | ﹤0.01% | 2365 |
|
|
2025
Q1 | $325K | Hold |
91,341
| – | – | ﹤0.01% | 2171 |
|
|
2024
Q4 | $677K | Hold |
91,341
| – | – | ﹤0.01% | 1885 |
|
|
2024
Q3 | $857K | Hold |
91,341
| – | – | ﹤0.01% | 1752 |
|
|
2024
Q2 | $731K | Sell |
91,341
-1,131
| -1% | -$9.05K | ﹤0.01% | 1790 |
|
|
2024
Q1 | $1.37M | Sell |
92,472
-15
| -0% | -$222 | ﹤0.01% | 1475 |
|
|
2023
Q4 | $751K | Sell |
92,487
-50
| -0.1% | -$406 | ﹤0.01% | 1790 |
|
|
2023
Q3 | $422K | Buy |
92,537
+88
| +0.1% | +$401 | ﹤0.01% | 2021 |
|
|
2023
Q2 | $650K | Buy |
92,449
+39,821
| +76% | +$280K | ﹤0.01% | 1841 |
|
|
2023
Q1 | $321K | Buy |
52,628
+28,584
| +119% | +$175K | ﹤0.01% | 2250 |
|
|
2022
Q4 | $154K | Sell |
24,044
-24,046
| -50% | -$154K | ﹤0.01% | 2252 |
|
|
2022
Q3 | $462K | Buy |
48,090
+24,021
| +100% | +$231K | ﹤0.01% | 1994 |
|
|
2022
Q2 | $265K | Buy |
24,069
+68
| +0.3% | +$749 | ﹤0.01% | 2154 |
|
|
2022
Q1 | $399K | Buy |
24,001
+16
| +0.1% | +$266 | ﹤0.01% | 2036 |
|
|
2021
Q4 | $458K | Buy |
+23,985
| New | +$458K | ﹤0.01% | 1944 |
|
|
2021
Q2 | – | Sell |
-78,211
| Closed | -$2.48M | – | 1638 |
|
|
2021
Q1 | $2.48M | Buy |
78,211
+60,207
| +334% | +$1.91M | ﹤0.01% | 1144 |
|
|
2020
Q4 | $834K | Buy |
+18,004
| New | +$834K | ﹤0.01% | 1219 |
|